UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated KRAS G12C-Mutated Non-Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100

Journal of clinical oncology, 2023-06, Vol.41 (18), p.3311-3317

2023

Volltextzugriff (PDF)

Sensitive Detection of Exosomal Proteins via a Compact Surface Plasmon Resonance Biosensor for Cancer Diagnosis

ACS sensors, 2018-08, Vol.3 (8), p.1471-1479

2018

Volltextzugriff (PDF)

Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: Case Series and Review of the Literature

Case reports in oncology, 2019-01, Vol.12 (1), p.260-276

2019

Volltextzugriff (PDF)

Prolonged disease control despite ALK inhibitor discontinuation in advanced ALK-positive NSCLC

European journal of case reports in internal medicine, 2024-04, Vol.11 (6), p.004527

2024

Volltextzugriff (PDF)

Small Cell Lung Cancer

Mayo Clinic proceedings, 2008-03, Vol.83 (3), p.355-367

2008

Volltextzugriff (PDF)

The Position of EGF Deprivation in the Management of Advanced Non-Small Cell Lung Cancer

Frontiers in oncology, 2021-06, Vol.11, p.639745

2021

Volltextzugriff (PDF)

Tumor Characteristics and Treatment Responsiveness in Pembrolizumab-Treated Non-Small Cell Lung Carcinoma

Cancers, 2024-02, Vol.16 (4), p.744

2024

Volltextzugriff (PDF)

PD-L1 Expression by RNA-Sequencing in Non-Small Cell Lung Cancer: Concordance with Immunohistochemistry and Associations with Pembrolizumab Treatment Outcomes

Cancers, 2023-09, Vol.15 (19), p.4789

2023

Volltextzugriff (PDF)

Understanding, recognizing, and managing toxicities of targeted anticancer therapies

CA: a cancer journal for clinicians, 2013-07, Vol.63 (4), p.249-279

2013

Volltextzugriff (PDF)

BRAF V600E disrupts AZD6244-induced abrogation of negative feedback pathways between extracellular signal-regulated kinase and Raf proteins

Cancer research (Chicago, Ill.), 2008-08, Vol.68 (15), p.6145-6153

2008

Volltextzugriff (PDF)

The role of focal adhesion kinase in lung cancer

Anti-cancer agents in medicinal chemistry, 2013-05, Vol.13 (4), p.581-583

Dy, Grace K

2013

Volltextzugriff (PDF)

Alterations in genes other than EGFR/ALK/ROS1 in non-small cell lung cancer：trials and treatment options

Cancer biology & medicine, 2016-03, Vol.13 (1), p.77-86

2016

Volltextzugriff (PDF)

Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC

Frontiers in oncology, 2022-08, Vol.12, p.958043-958043

2022

Volltextzugriff (PDF)

Pneumonectomy-Sparing NSAID Therapy for Pulmonary Inflammatory Myofibroblastic Tumor

Journal of thoracic oncology, 2015-09, Vol.10 (9), p.e89-e90

2015

Volltextzugriff (PDF)

Survival Benefit of Perioperative Systemic Chemotherapy for Patients With N0 to N1 NSCLC Having Synchronous Brain Metastasis

JTO clinical and research reports, 2023-06, Vol.4 (6), p.100522-100522, Article 100522

2023

Volltextzugriff (PDF)

Vitamin D3 Metabolites Demonstrate Prognostic Value in EGFR -Mutant Lung Adenocarcinoma and Can be Deployed to Oppose Acquired Therapeutic Resistance

Cancers, 2020-03, Vol.12 (3), p.675

2020

Volltextzugriff (PDF)

Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo

Journal of hepatology, 2012-01, Vol.56 (1), p.176-183

2012

Volltextzugriff (PDF)

Effects of Rovalpituzumab Tesirine on Ventricular Repolarization in Patients With Small‐Cell Lung Cancer

Clinical and translational science, 2021-03, Vol.14 (2), p.664-670

2021

Volltextzugriff (PDF)

Ocular adverse events associated with antibody-drug conjugates for cancer: evidence and management strategies

The oncologist (Dayton, Ohio), 2024-07

2024

Volltextzugriff (PDF)

Simultaneous Detection of Tumor Derived Exosomal Protein–MicroRNA Pairs with an Exo-PROS Biosensor for Cancer Diagnosis

ACS nano, 2023-05, Vol.17 (9), p.8108-8122

2023

Volltextzugriff (PDF)

First line treatment of advanced non-small-cell lung cancer - specific focus on albumin bound paclitaxel

International journal of nanomedicine, 2014-01, Vol.9 (Issue 1), p.209-221

2014

Volltextzugriff (PDF)

CodeBreak 200: study limitations, and future directions

Translational cancer research, 2024-01, Vol.13 (1), p.15-21

2024

Volltextzugriff (PDF)

JASPER: Phase 2 trial of first‐line niraparib plus pembrolizumab in patients with advanced non–small cell lung cancer

Cancer, 2022-01, Vol.128 (1), p.65-74

2022

Volltextzugriff (PDF)

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating Nintedanib Versus Placebo as Prophylaxis Against Radiation Pneumonitis in Patients With Unresectable NSCLC Undergoing Chemoradiation Therapy

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.e19-e20

2021

Volltextzugriff (PDF)

Trilaciclib use in extensive-stage small cell lung cancer (ES-SCLC): are clinical benefits seen in the real-world setting?

Supportive care in cancer, 2024-09, Vol.32 (9), p.622, Article 622

2024

Volltextzugriff (PDF)

1 – 25 von 153

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(135)
Mit Volltextzugriff
(141)

Publikationsform

Sprache

Englisch
(152)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(59)
Life Sciences & Biomedicine
(57)
Oncology
(44)
Humans
(32)
Lung Cancer
(16)
Lung Neoplasms - Drug Therapy
(12)
Tumors
(11)
Immunotherapy
(10)
Non-Small Cell Lung Cancer
(10)
Patients
(10)
Biological And Medical Sciences
(9)
Chemotherapy
(9)
Medical Sciences
(9)
Respiratory System
(9)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(8)
Animals
(7)
Cancer
(7)
Female
(7)
Neoplasms - Drug Therapy
(6)
Cancer Therapies
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated KRAS G12C-Mutated Non-Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100

Sensitive Detection of Exosomal Proteins via a Compact Surface Plasmon Resonance Biosensor for Cancer Diagnosis

Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: Case Series and Review of the Literature

Prolonged disease control despite ALK inhibitor discontinuation in advanced ALK-positive NSCLC

Small Cell Lung Cancer

The Position of EGF Deprivation in the Management of Advanced Non-Small Cell Lung Cancer

Tumor Characteristics and Treatment Responsiveness in Pembrolizumab-Treated Non-Small Cell Lung Carcinoma

PD-L1 Expression by RNA-Sequencing in Non-Small Cell Lung Cancer: Concordance with Immunohistochemistry and Associations with Pembrolizumab Treatment Outcomes

Understanding, recognizing, and managing toxicities of targeted anticancer therapies

BRAF V600E disrupts AZD6244-induced abrogation of negative feedback pathways between extracellular signal-regulated kinase and Raf proteins

The role of focal adhesion kinase in lung cancer

Alterations in genes other than EGFR/ALK/ROS1 in non-small cell lung cancer：trials and treatment options

Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC

Pneumonectomy-Sparing NSAID Therapy for Pulmonary Inflammatory Myofibroblastic Tumor

Survival Benefit of Perioperative Systemic Chemotherapy for Patients With N0 to N1 NSCLC Having Synchronous Brain Metastasis

Vitamin D3 Metabolites Demonstrate Prognostic Value in EGFR -Mutant Lung Adenocarcinoma and Can be Deployed to Oppose Acquired Therapeutic Resistance

Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo

Effects of Rovalpituzumab Tesirine on Ventricular Repolarization in Patients With Small‐Cell Lung Cancer

Ocular adverse events associated with antibody-drug conjugates for cancer: evidence and management strategies

Simultaneous Detection of Tumor Derived Exosomal Protein–MicroRNA Pairs with an Exo-PROS Biosensor for Cancer Diagnosis

First line treatment of advanced non-small-cell lung cancer - specific focus on albumin bound paclitaxel

CodeBreak 200: study limitations, and future directions

JASPER: Phase 2 trial of first‐line niraparib plus pembrolizumab in patients with advanced non–small cell lung cancer

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating Nintedanib Versus Placebo as Prophylaxis Against Radiation Pneumonitis in Patients With Unresectable NSCLC Undergoing Chemoradiation Therapy

Trilaciclib use in extensive-stage small cell lung cancer (ES-SCLC): are clinical benefits seen in the real-world setting?

Aktive Filter

Suchergebnisse filtern